<DOC>
	<DOCNO>NCT02994147</DOCNO>
	<brief_summary>Repeated joint bleeding lead hemophilic arthropathy ( HA ) , manifest chronic synovitis , cartilage damage bony destruction . Currently available treatment HA , include analgesic , NSAIDs , hyaluronic acid , predominantly direct toward symptomatic relief pain inflammation , little effect joint cartilage degeneration . AC201CR , control release formulation AC-201 , demonstrate anti-inflammatory effect reduce NLRP3 inflammasome assembly . AC-201 also unique influence anabolism catabolism chondrocytes vitro show cartilage-sparing property animal study . The study design evaluate joint structure-modifying symptom-relieving effect , safety , tolerability AC-201CR subject HA .</brief_summary>
	<brief_title>A Proof-of-Concept Study AC-201 Controlled-Release Tablet ( CR Tablet ) Patients With Hemophilic Arthropathy</brief_title>
	<detailed_description />
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>1 . Male age 20 65 year , inclusive 2 . Diagnosis Hemophilia A B 3 . Clinical diagnosis hemophilic arthropathy knee ( ) least 6 month 4 . Pettersson score ( base Xray ) 0 4 least one knee within 1 year screen 5 . IPSG ( 2012 ) overall score 3 9 ( base MRI ) least one knee screen 6 . Is able read , understand , sign Informed Consent Form ( ICF ) , communicate investigator , complete study diary , understand comply protocol requirement 1 . Total knee replacement primary knee 2 . Presence joint infection primary knee 3 . Knee surgery within 6 month prior screen primary knee 4 . Intraarticular hyaluronic acid ( IAHA ) plateletrich plasma ( PRP ) injection primary knee within 6 month prior screen 5 . Use following medication screen visit : 1 . NSAID injection ( oral NSAIDs include COX2 inhibitor allow ) 2 . Glucosamine chondroitin 6 . History high responder inhibitory antibody factor VIII factor IX clotting factor , titer &gt; 5 Bethesda unit ( BU ) , OR clinical evidence presence factor inhibitor 7 . History rheumatoid arthritis gouty arthropathy 8 . Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) concentration &gt; 2x upper limit laboratory normal range ( ULN ) , bilirubin &gt; 1.5x ULN screen 9 . Positive test human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) , TB</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>